CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −75,000 | $25.46 | $1.9M | 528,621 |
| 2026-07-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −10,700 | $27.24 | $291K | 603,621 |
| 2026-06-30 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −58,000 | $25.94 | $1.5M | 631,321 |
| 2026-06-30 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −17,000 | $26.82 | $456K | 614,321 |
| 2026-04-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −15,730 | $26.83 | $422K | 689,321 |
| 2026-03-31 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −19,364 | $25.50 | $494K | 760,687 |
| 2026-03-31 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −55,183 | $26.54 | $1.5M | 705,504 |
| 2026-03-31 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −453 | $27.05 | $12K | 705,051 |
| 2026-02-19 | Congleton Jon Chief Executive Officer | Grant or award | +140,900 | 780,051 | ||
| 2026-02-19 | Congleton Jon Chief Executive Officer | Grant or award · Stock Option | +187,900 | 187,900 | ||
| 2026-01-12 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −9,119 | $32.21 | $294K | 646,268 |
| 2026-01-12 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −7,117 | $33.15 | $236K | 639,151 |
| 2025-11-21 | Congleton Jon Chief Executive Officer | Option exercise | +24,082 | $0.54 | $13K | 655,387 |
| 2025-11-21 | Congleton Jon Chief Executive Officer | Option exercise · Stock Option | −24,082 | 0 | ||
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −12,806 | $41.64 | $533K | 818,499 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −8,862 | $42.31 | $375K | 809,637 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −4,000 | $43.50 | $174K | 805,637 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −29,207 | $45.20 | $1.3M | 776,430 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −112,275 | $45.83 | $5.1M | 664,155 |
| 2025-11-11 | Congleton Jon Chief Executive Officer | Sale | −32,850 | $46.89 | $1.5M | 631,305 |
Page 1 of 2 · 27 trades